DrugPatentWatch Database Preview
Details for Patent: 9,592,253
Email this page to a colleague
See Plans and PricingWhich drugs does patent 9,592,253 protect, and when does it expire?
Patent 9,592,253 protects LOKELMA and is included in one NDA.
This patent has eighteen patent family members in seventeen countries.
Summary for Patent: 9,592,253
| Title: | Extended use zirconium silicate compositions and methods of use thereof |
| Abstract: | The present invention relates to zirconium silicate compositions having a lead content that is below 0.6 ppm and methods of manufacturing zirconium silicate at reactor volumes exceeding 200-L with a lead content below 1.1 ppm. The lead content of the zirconium silicate of this invention are within the levels that are considered acceptable for extended use given the dose requirements for zirconium silicate. |
| Inventor(s): | Keyser; Donald Jeffrey (Southlake, TX), Guillem; Alvaro F. (Lantana, TX) |
| Assignee: | ZS PHARMA, INC. (Coppell, TX) |
| Application Number: | 14/883,428 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Process; |
Drugs Protected by US Patent 9,592,253
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Astrazeneca Pharms | LOKELMA | sodium zirconium cyclosilicate | FOR SUSPENSION;ORAL | 207078-001 | May 18, 2018 | RX | Yes | No | Start Trial | Start Trial | Y | TREATMENT OF HYPERKALEMIA IN ADULTS | Start Trial | |||
| Astrazeneca Pharms | LOKELMA | sodium zirconium cyclosilicate | FOR SUSPENSION;ORAL | 207078-002 | May 18, 2018 | RX | Yes | Yes | Start Trial | Start Trial | Y | TREATMENT OF HYPERKALEMIA IN ADULTS | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,592,253
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 106369 | Start Trial | |||
| Australia | 2016338753 | Start Trial | |||
| Brazil | 112018007189 | Start Trial | |||
| Canada | 3000950 | Start Trial | |||
| Chile | 2018000916 | Start Trial | |||
| China | 108137620 | Start Trial | |||
| Costa Rica | 20180276 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
